These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29554199)

  • 1. Relative Performance of Propensity Score Matching Strategies for Subgroup Analyses.
    Wang SV; Jin Y; Fireman B; Gruber S; He M; Wyss R; Shin H; Ma Y; Keeton S; Karami S; Major JM; Schneeweiss S; Gagne JJ
    Am J Epidemiol; 2018 Aug; 187(8):1799-1807. PubMed ID: 29554199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the performance of different methods for propensity score matched subgroup analyses and a summary of their application in peer-reviewed research studies.
    Wang SV; He M; Jin Y; Wyss R; Shin H; Ma Y; Keeton S; Fireman B; Karami S; Major JM; Schneeweiss S; Gagne JJ
    Pharmacoepidemiol Drug Saf; 2017 Dec; 26(12):1507-1512. PubMed ID: 28984001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of propensity score methods for pre-specified subgroup analysis with survival data.
    Izem R; Liao J; Hu M; Wei Y; Akhtar S; Wernecke M; MaCurdy TE; Kelman J; Graham DJ
    J Biopharm Stat; 2020 Jul; 30(4):734-751. PubMed ID: 32191555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the use of bootstrapping in cohort studies conducted with 1:1 propensity score matching-A plasmode simulation study.
    Desai RJ; Wyss R; Abdia Y; Toh S; Johnson M; Lee H; Karami S; Major JM; Nguyen M; Wang SV; Franklin JM; Gagne JJ
    Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):879-886. PubMed ID: 31020732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Comparison of US Food and Drug Administration Sentinel Analysis Tools to Traditional Approaches in Quantifying a Known Drug-Adverse Event Association.
    Gagne JJ; Han X; Hennessy S; Leonard CE; Chrischilles EA; Carnahan RM; Wang SV; Fuller C; Iyer A; Katcoff H; Woodworth TS; Archdeacon P; Meyer TE; Schneeweiss S; Toh S
    Clin Pharmacol Ther; 2016 Nov; 100(5):558-564. PubMed ID: 27416001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system.
    Rassen JA; Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():41-9. PubMed ID: 22262592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivariable confounding adjustment in distributed data networks without sharing of patient-level data.
    Toh S; Reichman ME; Houstoun M; Ding X; Fireman BH; Gravel E; Levenson M; Li L; Moyneur E; Shoaibi A; Zornberg G; Hennessy S
    Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1171-7. PubMed ID: 23878013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the ability of double-robust estimators to correct bias in propensity score matching analysis. A Monte Carlo simulation study.
    Nguyen TL; Collins GS; Spence J; Devereaux PJ; Daurès JP; Landais P; Le Manach Y
    Pharmacoepidemiol Drug Saf; 2017 Dec; 26(12):1513-1519. PubMed ID: 28984050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance evaluation of regression splines for propensity score adjustment in post-market safety analysis with multiple treatments.
    Tian Y; Baro E; Zhang R
    J Biopharm Stat; 2019; 29(5):810-821. PubMed ID: 31502924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propensity score balance measures in pharmacoepidemiology: a simulation study.
    Ali MS; Groenwold RH; Pestman WR; Belitser SV; Roes KC; Hoes AW; de Boer A; Klungel OH
    Pharmacoepidemiol Drug Saf; 2014 Aug; 23(8):802-11. PubMed ID: 24478163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses.
    Rassen JA; Glynn RJ; Rothman KJ; Setoguchi S; Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2012 Jul; 21(7):697-709. PubMed ID: 22162077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the Utility of Coarsened Exact Matching for Pharmacoepidemiology Using Real and Simulated Claims Data.
    Ripollone JE; Huybrechts KF; Rothman KJ; Ferguson RE; Franklin JM
    Am J Epidemiol; 2020 Jun; 189(6):613-622. PubMed ID: 31845719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable selection for propensity score models when estimating treatment effects on multiple outcomes: a simulation study.
    Wyss R; Girman CJ; LoCasale RJ; Brookhart AM; Stürmer T
    Pharmacoepidemiol Drug Saf; 2013 Jan; 22(1):77-85. PubMed ID: 23070806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is size the next big thing in epidemiology?
    Toh S; Platt R
    Epidemiology; 2013 May; 24(3):349-51. PubMed ID: 23549179
    [No Abstract]   [Full Text] [Related]  

  • 15. Propensity Score Weighting and Trimming Strategies for Reducing Variance and Bias of Treatment Effect Estimates: A Simulation Study.
    Stürmer T; Webster-Clark M; Lund JL; Wyss R; Ellis AR; Lunt M; Rothman KJ; Glynn RJ
    Am J Epidemiol; 2021 Aug; 190(8):1659-1670. PubMed ID: 33615349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating subgroup effects using the propensity score method: a practical application in outcomes research.
    Eeren HV; Spreeuwenberg MD; Bartak A; de Rooij M; Busschbach JJ
    Med Care; 2015 Apr; 53(4):366-73. PubMed ID: 25738381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to perform prespecified subgroup analyses when using propensity score methods in the case of imbalanced subgroups.
    Chatelet F; Verillaud B; Chevret S
    BMC Med Res Methodol; 2023 Oct; 23(1):255. PubMed ID: 37907863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metrics for covariate balance in cohort studies of causal effects.
    Franklin JM; Rassen JA; Ackermann D; Bartels DB; Schneeweiss S
    Stat Med; 2014 May; 33(10):1685-99. PubMed ID: 24323618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Merits and caveats of propensity scores to adjust for confounding.
    Fu EL; Groenwold RHH; Zoccali C; Jager KJ; van Diepen M; Dekker FW
    Nephrol Dial Transplant; 2019 Oct; 34(10):1629-1635. PubMed ID: 30215791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of propensity scores, disease risk scores, and regression in confounder adjustment for the safety of emerging treatment with group sequential monitoring.
    Xu S; Shetterly S; Cook AJ; Raebel MA; Goonesekera S; Shoaibi A; Roy J; Fireman B
    Pharmacoepidemiol Drug Saf; 2016 Apr; 25(4):453-61. PubMed ID: 26875591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.